The First Cholesterol-Dominant, Barrier-Bettering Cosmeceutical
Built on more than two decades of original bench research, Epionce pioneered cholesterol-dominant formulations designed to optimize the skin barrier. Founded by clinical dermatologist Carl R. Thornfeldt, MD, FAAD, Epionce is rooted in a medical heritage guided by the principle of doing no harm — delivering clinically proven results without compromising barrier integrity.
Proven Formulas Powered by Botanicals
Epionce formulations combine therapeutic botanical ingredients at clinically effective concentrations with well-established actives such as salicylic acid and azelaic acid. Paired with a proprietary delivery system, Epionce technologies help block inflammatory factors, repair and strengthen the skin barrier, and visibly improve skin texture.
Evidence-Based Skincare with Measurable Results
In nearly 20 independent, head-to-head clinical trials, Epionce has demonstrated safety and efficacy across multiple skin concerns without harsh side effects, making it well-suited for sensitive skin. Finished, market-ready products have been studied against prescription therapies, showing visible improvement in aging, hyperpigmentation, erythema, acne, eczema, and other compromised skin conditions — while preserving the skin barrier.
Multitasking Regimens for Everyday Use
Since 2002, skin care professionals have trusted Epionce for gentle, effective, customizable regimens. All formulas are paraben-free, fragrance-free, sulfate-free, gluten-free, and cruelty-free. Whether addressing aging or complex skin conditions, Epionce regimens are simple, multitasking, and designed to optimize barrier health without irritation.
Ready to learn more about our barrier-bettering, evidence-based regimens for your practice? Meet us at Booth #1549